XML 86 R70.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting - Schedule of Segment Revenue Reconciled to Consolidated Net Loss (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenue: $ 7,696 $ 1,039 $ 4,013
Less:      
Cost of product revenue (1,076) 0 0
Selling, general and administrative      
Selling, general and administrative (191,331) (99,737) (58,094)
Research and development expenses      
Total research and development expenses (332,058) (240,156) (168,527)
Total other income, net 51,632 40,916 13,277
Income tax expense (180) 0 0
Loss on equity method investment 0 (470) (5,198)
Net loss (465,317) (298,408) (214,529)
Product revenue, net      
Segment Reporting Information [Line Items]      
Revenue: 5,420 0 0
Collaboration and license revenue      
Segment Reporting Information [Line Items]      
Revenue: 2,276 1,039 4,013
Reportable Segment      
Segment Reporting Information [Line Items]      
Revenue: 7,696 1,039 4,013
Less:      
Cost of product revenue (1,076) 0 0
Selling, general and administrative      
External selling, general and administrative expenses (90,013) (38,733) (20,362)
Selling, general and administrative personnel expenses (60,638) (32,285) (19,428)
Selling, general and administrative stock-based compensation (40,680) (28,719) (18,304)
Selling, general and administrative (191,331) (99,737) (58,094)
Research and development expenses      
Paltusotine (68,337) (51,229) (46,772)
Atumelnant (48,131) (24,524) (13,118)
Other research and development programs (33,322) (26,010) (20,421)
Research and development personnel expenses (102,677) (70,772) (53,446)
Research and development stock-based compensation (50,344) (40,667) (22,633)
Other research and development (29,247) (26,954) (12,137)
Total research and development expenses (332,058) (240,156) (168,527)
Total other income, net 51,632 40,916 13,277
Income tax expense (180) 0 0
Loss on equity method investment 0 (470) (5,198)
Net loss (465,317) (298,408) (214,529)
Reportable Segment | Product revenue, net      
Segment Reporting Information [Line Items]      
Revenue: 5,420 0 0
Reportable Segment | Collaboration and license revenue      
Segment Reporting Information [Line Items]      
Revenue: $ 2,276 $ 1,039 $ 4,013